The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients

被引:0
作者
Azhar M. Nomair
Abeer Abdelati
Fatma I. Dwedar
Rehab Elnemr
Yasmine N. Kamel
Hanan M. Nomeir
机构
[1] Alexandria University,Department of Chemical Pathology, Medical Research Institute
[2] Alexandria University,Department of Internal Medicine, Rheumatology and Clinical Immunology Unit, Faculty of Medicine
[3] Alexandria University,Department of Medical Biochemistry, Faculty of Medicine
[4] Alexandria University,Department of Physical Medicine Rheumatology and Rehabilitation, Faculty of Medicine
来源
Clinical Rheumatology | 2024年 / 43卷
关键词
ATIC; Methotrexate; RFC-1; Rheumatoid arthritis; TYMS; Variant;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:971 / 983
页数:12
相关论文
共 50 条
  • [31] Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis
    Hartman, M
    van Ede, AE
    Severens, JL
    Laan, RFJM
    van de Putte, LBA
    van der Wilt, GJ
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (05) : 902 - 908
  • [32] Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis
    James, Heather M.
    Gillis, David
    Hissaria, Pravin
    Lester, Susan
    Somogyi, Andrew A.
    Cleland, Leslie G.
    Proudman, Susanna M.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (04) : 562 - 571
  • [33] Combination therapy for rheumatoid arthritis with methotrexate and cyclosporine
    T. Pincus
    Zeitschrift für Rheumatologie, 1998, 57 : 34 - 36
  • [34] Sustained cough in methotrexate therapy for rheumatoid arthritis
    Schnabel, A
    Dalhoff, K
    Bauerfeind, S
    Barth, J
    Gross, WL
    CLINICAL RHEUMATOLOGY, 1996, 15 (03) : 277 - 282
  • [35] Genetic variants influencing response to methotrexate in juvenile idiopathic arthritis and rheumatoid arthritis
    Ranganathan, Prabha
    RHEUMATOLOGY INTERNATIONAL, 2016, 36 (01) : 53 - 54
  • [36] Genetic variants influencing response to methotrexate in juvenile idiopathic arthritis and rheumatoid arthritis
    Prabha Ranganathan
    Rheumatology International, 2016, 36 : 53 - 54
  • [37] Contribution of common polymorphisms in reduced folate carrier and γ-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis
    Dervieux, T
    Kremer, J
    Lein, DO
    Capps, R
    Barham, R
    Meyer, G
    Smith, K
    Caldwell, J
    Furst, DE
    PHARMACOGENETICS, 2004, 14 (11): : 733 - 739
  • [38] Folate-targeted nanoparticles for rheumatoid arthritis therapy
    Nogueira, Eugenia
    Gomes, Andreia C.
    Preto, Ana
    Cavaco-Paulo, Artur
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2016, 12 (04) : 1113 - 1126
  • [39] Using subcutaneous methotrexate to prolong duration of methotrexate therapy in rheumatoid arthritis
    Harris, Emily
    Ng, Bernard
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2018, 5 (02) : 85 - 91
  • [40] Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate
    Carmichael, SJ
    Beal, J
    Day, RO
    Tett, SE
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (10) : 2077 - 2083